Indicated for adults and pediatric patients 12 years and older with metastatic Merkel Cell Carcinoma (MCC)
Indicated for the maintenance treatment of patients with locally advanced or metastatic Urothelial Carcinoma (UC) that has not progressed with first-line platinum-containing chemotherapy
Indicated for patients with locally advanced or metastatic UC who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy
Indicated for first-line treatment, in combination with axitinib, of patients with advanced Renal Cell Carcinoma (RCC)
